Limited Competition: Small Research Grant Program for NIAID K01/K08/K23 Recipients (R03)
Funding Opportunity PAR-17-439 from the NIH Guide for Grants and Contracts. The National Institute of Allergy and Infectious Diseases (NIAID) announces a program that provides NIAID-supported K01, K08, and K23 recipients with the opportunity to apply for Small Research Grant (R03) support at some point during the final two years of their K award. Through the use of this mechanism, NIAID seeks to enhance the capability of its K01, K08, and K23 award recipients to conduct research as they complete their transition to fully independent investigator status (e.g., R01 support). The R03 grant mechanism supports different type...
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 28, 2017 Category: Research Source Type: funding

Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion (R01)
Funding Opportunity PA-17-330 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity (FOA) is to stimulate research on the identification of new and novel targets and mechanisms involved in tumor immune evasion, which may be amenable to analysis by small molecules, pharmacological, or molecular genetics approaches. A specific focus of this FOA is to encourage cross disciplinary collaborations between immunologists, cell biologists, medicinal chemists, pharmacologists, and molecular biologists. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - July 20, 2017 Category: Research Source Type: funding

Limited Competition: Follow-up on Subjects and Immunological Assessments in The Environmental Determinants of Diabetes In The Young Study (TEDDY) (UC4)
Funding Opportunity RFA-DK-17-508 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites an application from the Program Director/Principal Investigator (PD/PI) of the current Data Coordinating Center (DCC) for The Environmental Determinants of Diabetes in the Young (TEDDY) study, an ongoing epidemiological study. This DCC has been involved in study design and data and biosample acquisition and management since the inception of the TEDDY Consortium. This FOA provides support for the TEDDY DCC to continue to follow TEDDY children, allowing collaborators to conduct further studies...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 26, 2017 Category: Research Source Type: funding

Updated Resource for Clinical Regulations Across the Globe
NIH’s National Institute of Allergy and Infectious Diseases (NIAID) ClinRegs website provides clinical regulations for countries around the world. Since its initial release, the site has undergone several functionality upgrades to make the site easier to use. The updated site includes: A new interactive map on the homepage to provide a clearer picture of the countries included A hyperlinked table of contents on each country page for easier navigation Drop-down menus to switch between country profiles and country comparisons A “Quick Facts” table with discrete pieces of information for each country A feed...
Source: NIH Extramural Nexus - April 26, 2017 Category: Research Authors: NIH Staff Tags: New Resources Source Type: funding

Limited Competition: Follow-up on Subjects and Immunological Assessments in The Environmental Determinants of Diabetes In The Young Study (TEDDY) (UC4)
This Funding Opportunity Announcement (FOA) invites an application from the Program Director/Principal Investigator (PD/PI) of the current Data Coordinating Center (DCC) for The Environmental Determinants of Diabetes in the Young (TEDDY) study, an ongoing epidemiological study. This DCC has been involved in study design and data and biosample acquisition and management since the inception of the TEDDY Consortium. This FOA provides support for the TEDDY DCC to continue to follow TEDDY children, allowing collaborators to conduct further studies in the measurement and analysis of immune markers using samples from TEDDY subjec...
Source: NIDDK Funding Opportunities - April 26, 2017 Category: Endocrinology Source Type: funding

Activities to Promote Research Collaborations on Immune-Related Adverse Events (APRC-irAEs) Associated with Cancer Immunotherapy (Admin Supp)
Funding Opportunity ID: 292958 Opportunity Number: PA-17-248 Opportunity Title: Activities to Promote Research Collaborations on Immune-Related Adverse Events (APRC-irAEs) Associated with Cancer Immunotherapy (Admin Supp)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: EducationHealthCategory Explanation: CFDA Number(s): 93.39693.84693.855Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher...
Source: Grants.gov - April 3, 2017 Category: Research Tags: Education Health Source Type: funding

Activities to Promote Research Collaborations on Immune-Related Adverse Events (APRC-irAEs) Associated with Cancer Immunotherapy (Admin Supp)
Funding Opportunity PA-17-248 from the NIH Guide for Grants and Contracts. The overarching goal of this Funding Opportunity Announcement (FOA) is to support collaborative pilot projects to generate new ideas and approaches to reduce the incidence and/or severity of auto-inflammatory or autoimmune adverse events in the setting of cancer immunotherapy. In order to facilitate formation of multidisciplinary teams with expertise in mechanisms of cancer immunology/immunotherapy as well as immune tolerance and/or autoimmunity, teams that include (a) a current NCI grantee and a current NIAID grantee, or (b) a current NCI grante...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 3, 2017 Category: Research Source Type: funding

Cancer Immune Monitoring and Analysis Centers (U24)
Funding Opportunity ID: 290775 Opportunity Number: RFA-CA-17-005 Opportunity Title: Cancer Immune Monitoring and Analysis Centers (U24)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: EducationHealthCategory Explanation: CFDA Number(s): 93.39493.395Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public ho...
Source: Grants.gov - February 19, 2017 Category: Research Tags: Education Health Source Type: funding

Cancer Immunologic Data Commons (CIDC) (U24)
Funding Opportunity ID: 290776 Opportunity Number: RFA-CA-17-006 Opportunity Title: Cancer Immunologic Data Commons (CIDC) (U24)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: EducationHealthCategory Explanation: CFDA Number(s): 93.39493.395Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing a...
Source: Grants.gov - February 19, 2017 Category: Research Tags: Education Health Source Type: funding

NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01)
Funding Opportunity ID: 291114 Opportunity Number: PA-17-114 Opportunity Title: NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.85593.856Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing auth...
Source: Grants.gov - February 19, 2017 Category: Research Tags: Health Source Type: funding

Notice of Change to RFA-CA-17-006 "Cancer Immunologic Data Commons (CIDC) (U24)" to Include Collection and Analysis of Data for Specimens from Immunotherapy Trials for Pediatric Cancer Patients
Notice NOT-CA-17-025 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 27, 2017 Category: Research Source Type: funding

Notice of Change of Key Dates for RFA-CA-17-006 "Cancer Immunologic Data Commons (CIDC) (U24)"
Notice NOT-CA-17-020 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 25, 2017 Category: Research Source Type: funding

NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01)
Funding Opportunity ID: 291114 Opportunity Number: PA-17-114 Opportunity Title: NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: GrantCategory of Funding Activity: HealthCategory Explanation: CFDA Number(s): 93.85593.856Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing auth...
Source: Grants.gov - January 9, 2017 Category: Research Tags: Health Source Type: funding

NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01)
Funding Opportunity PA-17-114 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support multidisciplinary, hypothesis-driven research on Natural Killer (NK) cells, leading to the discovery of pathways relevant for early immune responses and immune regulation impacting the potential protective immunity to be induced by HIV vaccination. Secondary objectives include the development of novel technologies to allow for more definitive studies of human immune monitoring in the context of vaccine clinical trials and the recruitment of innate immunologists to the HIV va...
Source: NIH Funding Opportunities (Notices, PA, RFA) - January 9, 2017 Category: Research Source Type: funding

Cancer Immunologic Data Commons (CIDC) (U24)
Funding Opportunity ID: 290776 Opportunity Number: RFA-CA-17-006 Opportunity Title: Cancer Immunologic Data Commons (CIDC) (U24)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: EducationHealthCategory Explanation: CFDA Number(s): 93.39493.395Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing a...
Source: Grants.gov - December 17, 2016 Category: Research Tags: Education Health Source Type: funding